Consistent with these lines of evidence, we and other groups previously reported that inhibition of CXCR3 function or antagonism of its ligands significantly impeded the development and onset of SS-like sialadenitis and xerostomia by reducing effector T cell infiltration of SMGs in SS mouse models [17,18]. This evidence concerns the gene CXCR3 and synovial sarcoma.